GSK to Close Dresden Vaccine Plant by 2028, Affecting More Than 600 Jobs
GlaxoSmithKline plans to shut its Dresden vaccine manufacturing site by 2028 because of weaker global vaccine demand and higher production costs, eliminating more than 600 skilled industrial positions.